Nerai
1 known investors
Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.
AI & Machine LearningBiotechHealthtech
Investors Β· 1
Frequently asked questions
- What does Nerai do?
- Nerai is a biotechnology company developing personalized CRISPR-based genome editors through its MORPHEME platform, which combines automated directed evolution, high-throughput functional screening, and machine learning. It focuses on one-time genetic therapies for rare inherited diseases, with initial programs targeting the liver and retina.
- Who are Nerai's investors?
- Nerai's investors include Kickfund.